Keros Therapeutics Investor Relations Material
Latest events
Status Update
Keros Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Keros Therapeutics Inc
Access all reports
Keros Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of novel treatments aimed at addressing unmet medical needs in hematological, pulmonary, and cardiovascular disorders. By leveraging cutting-edge science, Keros is focused on creating therapies that have the potential to significantly improve patient outcomes. The company's research and development efforts are grounded in the transformative potential of TGF-β (transforming growth factor-beta) science. It is headquartered in Lexington, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Keros Therapeutics Inc
Status Update
Keros Therapeutics Inc
Status Update
Keros Therapeutics Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
KROS
Country
🇺🇸 United States